Weighing the Long-Term Use of Obesity Drugs Like Zepbound: A Growing Concern for Patients

Susana Parks, after losing 40 pounds on Eli Lilly’s Zepbound, now faces the challenge of maintaining her weight loss without the drug. As more people turn to obesity medications like Zepbound and Wegovy, questions about long-term use and potential withdrawal are becoming increasingly common. Dr. David Cummings of the University of Washington notes that patients…

Read More